TuHURA Biosciences, Inc./NV — Director's Dealing 2021

May 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kintara Therapeutics, Inc. (KTRA)
CIK: 0001498382
Period of Report: 2021-04-29

Reporting Person: SEYMOUR TAMARA A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-29	Options (Right to Grant)	$1.37	A	75000	Acquired	2031-04-29	Common Stock (75000)	Direct

Footnotes

F1: The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, one-third of the options vest on April 29, 2022, with the remaining options vesting in eight equal quarterly installments commencing on July 29, 2022.